Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 30,567.64 Crore) operating in Pharmaceuticals sector. Laurus Labs Ltd. key Products/Revenue Segments ...
Since that initial observation, clinical and experimental data suggest that patients with SAH and other intracranial diseases experience hypovolemia rather than the euvolemia or hypervolemia of SIADH.
Ninety percent of people in the United States eat too much salt, the body's main source of sodium. Although many people don't experience notable symptoms, eating too much salt can still cause ...